Feasibility of Hormones and Radiation for Intermediate or High Risk Prostate Cancer
Status:
Active, not recruiting
Trial end date:
2024-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is see if quality of life is improved in patients receiving oral
hormone therapy compared to standard of care. The study will also compare survival rates
between patients receiving oral hormone therapy and those receiving standard of care.